Stockreport

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF Multiple data readouts expected in 2024 for naporafenib (SEACRAFT-1), ERAS-007 (HERKULES-3), and ERAS-801 (THUNDERBBOLT-1) and planned initiation of pivotal SEACRAFT-2 [Read more]